146 related articles for article (PubMed ID: 2066185)
41. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
42. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
Jurin M; Suit HD
Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
[No Abstract] [Full Text] [Related]
43. Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes.
Hämmerling GJ; Klar D; Katzav S; Segal S; Feldman M; Wallich R; Hämmerling A
J Immunogenet; 1986; 13(2-3):153-7. PubMed ID: 3819449
[TBL] [Abstract][Full Text] [Related]
44. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
45. Reversible changes in tumor growth and metastatic behavior induced by immune pressure.
Yu S; McKhann CF; Flye MW
Surgery; 1990 Jan; 107(1):28-35. PubMed ID: 2296755
[TBL] [Abstract][Full Text] [Related]
46. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
47. Immunogenic neoplastic clones derived in vitro from an originally non-immunogenic BALB/c fibrosarcoma.
Carbone G; Parmiani G
Tumori; 1977; 63(6):513-8. PubMed ID: 601881
[TBL] [Abstract][Full Text] [Related]
48. In vitro demonstration of cryosurgical augmentation of tumor immunity.
Faraci RP; Bagley DH; Marrone J; Beazley RM
Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
[TBL] [Abstract][Full Text] [Related]
49. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
50. MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.
Romero I; Garrido C; Algarra I; Chamorro V; Collado A; Garrido F; Garcia-Lora AM
Front Immunol; 2018; 9():102. PubMed ID: 29434605
[TBL] [Abstract][Full Text] [Related]
51. Tumor growth in vivo selects for resistance to tumor necrosis factor.
Lattime EC; Stutman O
J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
[TBL] [Abstract][Full Text] [Related]
52. Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumor.
Schirrmacher V; Robinson P; Altevogt P; Radbruch A; Garrido F; Koszinowski U; Krog HH; Lundin L
Transplant Proc; 1981 Dec; 13(4):1819-23. PubMed ID: 6977218
[No Abstract] [Full Text] [Related]
53. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
Bhatnagar RM; Zabriskie JB; Rausen AR
J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
[TBL] [Abstract][Full Text] [Related]
54. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
55. Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.
Schmitt M; Ikeda H; Nagata Y; Gu X; Wang L; Kuribayashi K; Shiku H
Int J Cancer; 1997 Jul; 72(3):505-11. PubMed ID: 9247296
[TBL] [Abstract][Full Text] [Related]
56. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens.
Fritze D; Kern DH; Humme JA; Drogemuller CR; Pilch YH
Int J Cancer; 1976 Jan; 17(1):138-47. PubMed ID: 1248898
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the syngeneic anti-tumour response against the GR9 tumour with the production of isoantisera and monoclonal antibodies.
Delgado C; Garrido A; Pérez M; Garrido ML; Algarra I; Garrido F
J Immunogenet; 1986; 13(2-3):169-77. PubMed ID: 3819451
[TBL] [Abstract][Full Text] [Related]
58. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
Parmiani G; Colombo M; Ballinari D
Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
[TBL] [Abstract][Full Text] [Related]
59. [Current topics on tumor immunology].
Tachibana T
Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
[TBL] [Abstract][Full Text] [Related]
60. Castration effects on tumor specific immunity.
Brannen GE; Gomolka DM; Wettlaufer JN; Modarelli RO
Invest Urol; 1977 Jul; 15(1):28-38. PubMed ID: 873734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
